Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FT.3.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
JD.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JD.1.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
GJ.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GJ.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
HT.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HT.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FL.20NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.20SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
JH.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JH.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
CK.1.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CK.1.1.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
XBB.1.34.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.34.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
EG.2.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.2.5SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
JK.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JK.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
XBB.1.5.106NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.106SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
XBB.1.5.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.11SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FE.1.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FE.1.1.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FY.4.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FY.4.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
GZ.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GZ.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FT.3.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FT.3.1.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
EG.4.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.4.4SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
JZ.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JZ.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
HS.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HS.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
XBB.1.5.73NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.74 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.74 (Delta)SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.621.1 (Mu)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.621.1 (Mu)SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BA.2.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.5SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BF.7.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BF.7.5SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BF.32NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BF.32SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BQ.1.1.67NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.1.67SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used